Neurones (XPAR:NRO) EPS (Diluted) : €2.03 (TTM As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Neurones EPS (Diluted)?

Neurones's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was €0.98. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €2.03.

Neurones's EPS (Basic) for the six months ended in Dec. 2023 was €0.99. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was €2.04.

Neurones's EPS without NRI for the six months ended in Dec. 2023 was €0.98. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was €1.98.

During the past 12 months, Neurones's average EPS without NRIGrowth Rate was 10.20% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 17.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 14.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was 9.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Neurones's highest 3-Year average EPS without NRI Growth Rate was 415.30% per year. The lowest was -73.60% per year. And the median was 11.00% per year.

Neurones EPS (Diluted) Historical Data

The historical data trend for Neurones's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurones EPS (Diluted) Chart

Neurones Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Diluted)

Get a 7-Day Free Trial

1.27

1.56

1.82

2.03

Neurones Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EPS (Diluted)	Get a 7-Day Free Trial															0.80	0.91	0.91	1.05	0.98

Competitive Comparison of Neurones's EPS (Diluted)

For the Information Technology Services subindustry, Neurones's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurones's PE Ratio Distribution in the Software Industry

For the Software industry and Technology sector, Neurones's PE Ratio distribution charts can be found below:

* The bar in red indicates where Neurones's PE Ratio falls into.

Neurones EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Neurones's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(49.41	-	0)	/	24.313
	=	2.03

Neurones's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(23.989	-	0)	/	24.310
	=	0.99

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €2.03

Neurones (XPAR:NRO) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Neurones EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Neurones's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurones (XPAR:NRO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Neurones (XPAR:NRO) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

NE9:Germany

Address

Immeuble Le Clemenceau 1 - 205, Avenue Georges Clemenceau, Nanterre Cedex, Paris, FRA, 92024

Website

https://www.neurones.net

Neurones SA is a France-based technology sector company. Its core business involves the provision of Information Technology (IT) services catering to the needs of hardware, software, and consulting. Its operations are thereby divided into three segments: Infrastructure Services, Application Services, and Consulting. The Infrastructure segment is the strongest revenue driver through the provision of such services as IT operations, IT service management, systems and network, server, application, and workstation outsourcing. Its second most profitable business is carried out through the Application segment, which entails SAP, Web and decision support, social media, data analysis.